337 related articles for article (PubMed ID: 37469132)
21. An RNautophagy/DNautophagy receptor, LAMP2C, possesses an arginine-rich motif that mediates RNA/DNA-binding.
Fujiwara Y; Hase K; Wada K; Kabuta T
Biochem Biophys Res Commun; 2015 May; 460(2):281-6. PubMed ID: 25772617
[TBL] [Abstract][Full Text] [Related]
22. Direct uptake and degradation of DNA by lysosomes.
Fujiwara Y; Kikuchi H; Aizawa S; Furuta A; Hatanaka Y; Konya C; Uchida K; Wada K; Kabuta T
Autophagy; 2013 Aug; 9(8):1167-71. PubMed ID: 23839276
[TBL] [Abstract][Full Text] [Related]
23. Chaperone-mediated autophagy protects against hyperglycemic stress.
Vélez EJ; Schnebert S; Goguet M; Balbuena-Pecino S; Dias K; Beauclair L; Fontagné-Dicharry S; Véron V; Depincé A; Beaumatin F; Herpin A; Seiliez I
Autophagy; 2024 Apr; 20(4):752-768. PubMed ID: 37798944
[TBL] [Abstract][Full Text] [Related]
24. Splice variants of lysosome‑associated membrane proteins 2A and 2B are involved in sunitinib resistance in human renal cell carcinoma cells.
Nishikawa R; Osaki M; Sasaki R; Ishikawa M; Yumioka T; Yamaguchi N; Iwamoto H; Honda M; Kabuta T; Takenaka A; Okada F
Oncol Rep; 2020 Nov; 44(5):1810-1820. PubMed ID: 32901843
[TBL] [Abstract][Full Text] [Related]
25. Unique properties of lamp2a compared to other lamp2 isoforms.
Cuervo AM; Dice JF
J Cell Sci; 2000 Dec; 113 Pt 24():4441-50. PubMed ID: 11082038
[TBL] [Abstract][Full Text] [Related]
26. LAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated Autophagy.
Pérez L; McLetchie S; Gardiner GJ; Deffit SN; Zhou D; Blum JS
J Immunol; 2016 Mar; 196(6):2457-65. PubMed ID: 26856698
[TBL] [Abstract][Full Text] [Related]
27. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion.
Xia Y; Liu N; Xie X; Bi G; Ba H; Li L; Zhang J; Deng X; Yao Y; Tang Z; Yin B; Wang J; Jiang K; Li Z; Choi Y; Gong F; Cheng X; O'Shea JJ; Chae JJ; Laurence A; Yang XP
Autophagy; 2019 Jun; 15(6):960-975. PubMed ID: 30681394
[TBL] [Abstract][Full Text] [Related]
28. Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
Yao RQ; Ren C; Xia ZF; Yao YM
Autophagy; 2021 Feb; 17(2):385-401. PubMed ID: 32048886
[TBL] [Abstract][Full Text] [Related]
29. Molecular control of chaperone-mediated autophagy.
Catarino S; Pereira P; Girão H
Essays Biochem; 2017 Dec; 61(6):663-674. PubMed ID: 29233876
[TBL] [Abstract][Full Text] [Related]
30. Chaperone-mediated autophagy protects cardiomyocytes against hypoxic-cell death.
Ghosh R; Gillaspie JJ; Campbell KS; Symons JD; Boudina S; Pattison JS
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1555-C1575. PubMed ID: 35584327
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
32. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane.
Bandyopadhyay U; Kaushik S; Varticovski L; Cuervo AM
Mol Cell Biol; 2008 Sep; 28(18):5747-63. PubMed ID: 18644871
[TBL] [Abstract][Full Text] [Related]
33. The novel
Zhao J; Xu Z; Xie J; Liang T; Wang R; Chen W; Mi C; Tian P; Guo J; Zhang H
Autophagy; 2024 Jun; ():1-20. PubMed ID: 38836496
[TBL] [Abstract][Full Text] [Related]
34. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma.
Chava S; Lee C; Aydin Y; Chandra PK; Dash A; Chedid M; Thung SN; Moroz K; Wu T; Nayak NC; Dash S
Oncotarget; 2017 Jun; 8(25):40019-40036. PubMed ID: 28402954
[TBL] [Abstract][Full Text] [Related]
35. Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease.
Manso AM; Hashem SI; Nelson BC; Gault E; Soto-Hermida A; Villarruel E; Brambatti M; Bogomolovas J; Bushway PJ; Chen C; Battiprolu P; Keravala A; Schwartz JD; Shah G; Gu Y; Dalton ND; Hammond K; Peterson K; Saftig P; Adler ED
Sci Transl Med; 2020 Mar; 12(535):. PubMed ID: 32188720
[TBL] [Abstract][Full Text] [Related]
36. The chaperone-assisted selective autophagy complex dynamics and dysfunctions.
Tedesco B; Vendredy L; Timmerman V; Poletti A
Autophagy; 2023 Jun; 19(6):1619-1641. PubMed ID: 36594740
[TBL] [Abstract][Full Text] [Related]
37. Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma cells.
Magalhães-Novais S; Bermejo-Millo JC; Loureiro R; Mesquita KA; Domingues MR; Maciel E; Melo T; Baldeiras I; Erickson JR; Holy J; Potes Y; Coto-Montes A; Oliveira PJ; Vega-Naredo I
Autophagy; 2020 Feb; 16(2):313-333. PubMed ID: 30990357
[TBL] [Abstract][Full Text] [Related]
38. DYNC1LI2 regulates localization of the chaperone-mediated autophagy receptor LAMP2A and improves cellular homeostasis in cystinosis.
Rahman F; Johnson JL; Zhang J; He J; Pestonjamasp K; Cherqui S; Catz SD
Autophagy; 2022 May; 18(5):1108-1126. PubMed ID: 34643468
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of PLK3 Mediates the Degradation of Abnormal Prion Proteins Dependent on Chaperone-Mediated Autophagy.
Wang H; Tian C; Sun J; Chen LN; Lv Y; Yang XD; Xiao K; Wang J; Chen C; Shi Q; Shao QX; Dong XP
Mol Neurobiol; 2017 Aug; 54(6):4401-4413. PubMed ID: 27344333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
